What a DPP-4 inhibitor does
DPP-4 (dipeptidyl peptidase-4) is an enzyme that clears incretin hormones — including GLP-1 — out of your bloodstream within minutes of a meal. A DPP-4 inhibitor, the drug class nicknamed “gliptins,” simply gets in the enzyme’s way. With DPP-4 working more slowly, the GLP-1 and GIP your gut naturally releases stick around a bit longer, nudging your pancreas to release more insulin when blood sugar rises. These are oral pills used in type 2 diabetes.
Why it matters if you’re looking at GLP-1s
This is the cleanest way to understand where GLP-1 medications fit. A DPP-4 inhibitor preserves your own GLP-1 by slowing its breakdown — a gentle, behind-the-scenes assist. A GLP-1 receptor agonist does something more direct: it replaces the hormone with an engineered version delivered at far higher, longer-lasting levels. That’s the core contrast. Boosting your natural supply a little produces modest blood-sugar effects and roughly weight-neutral results; flooding the receptors with a drug produces the appetite and weight changes people associate with GLP-1 medications.
What to keep in mind
Neither class is automatically “better” — they’re different tools for different goals, and some people take other diabetes drugs alongside them. Which one fits depends on your blood sugar, your weight goals, other conditions, and cost. Your prescriber is the right person to weigh those trade-offs; this is background to help that conversation make sense, not a recommendation.